-

International Organization of Vine and Wine (OIV) Officially Incorporates NMR Method in Compendium of International Methods of Analysis of Wines and Musts

ETTLINGEN, Germany--(BUSINESS WIRE)--Nuclear magnetic resonance (NMR) spectroscopy has been incorporated by the intergovernmental and International Organization of Vine and Wine (OIV) in its compendium of International Methods of Analysis of Wines and Musts, for the quantification of six key parameters in wine – glucose, malic acid, acetic acid, fumaric acid, shikimic acid and sorbic acid.

Traditionally, several analytical techniques with individual calibrations are needed to measure these parameters. Now, 1H-NMR can very accurately quantify a significantly higher number of compounds in wines – simultaneously, label-free and with a single calibration.

The advent of advanced techniques like 1H-NMR helps to complete the chain of authenticity in high-end wine supply chains. The 1H-NMR fingerprint contains hundreds of signals that, when combined with sophisticated statistics, allows the creation of robust databases, providing a reference for the contents, varietals, and regions of production of wines.

Bruker’s NMR Wine-Profiling™ 4.0 module is based on the 400 MHz NMR FoodScreener™ platform. Now, 1H-NMR profiling has been accepted by the OIV, and offers the direct, label-free quantification of 53 compounds in a single, automated measurement. This enables the verification of geographical origin, grape variety of monovarietal wines, and quality grade, e.g., of Spanish red wines. This addresses the increasing demand for assurance of the origin and integrity of wine from the vineyard to the point of sale, enhancing supply chain surveillance and protecting valuable brands.

Elena Meléndez Álvarez, Director at the Estación Enológica de Haro, La Rioja, Spain, commented: “The versatility of this equipment makes it possible to adapt the analyses to our client´s specific needs. A single analysis is enough to obtain information about over 50 wine metabolites. Until now, a wine laboratory would have had to use a combination of various methods to arrive at similar results. The NMR Wine-Profiling™ 4.0 module gives an overall view of the wine's main components, such as acidity and alcohol content and of minor ones, like polyphenols and amino acids.”

Dr. Iris Mangelschots, President of Bruker BioSpin’s Applied, Industrial and Clinical Division, commented: “The announcement of 1H-NMR as an official OIV method is an important step forward for the wine industry, and Bruker is proud to contribute high-value solutions that lead the way. Robust, quantitative wine-profiling by 1H-NMR is an easy-to-use, rapid and reliable test that provides growers and producers with the assurance of an authentication method to detect adulteration or fraud.”

Following this major milestone in NMR-based wine profiling, Bruker continues to innovate in NMR and is developing advanced food analysis solutions based on the principles of blockchain to identify adulteration in high value products such as honey, juice, spices and olive oil.

About the International Organization of Vine and Wine

The scientific and technical reference of the vine and wine world, the OIV is an intergovernmental organisation of a scientific and technical nature of recognised competence for its works concerning vines, wine, wine-based beverages, table grapes, raisins and other vine-based products. OIV’s standards are adopted by many wine producing countries. For more information, please visit: https://www.oiv.int/en/ or https://www.oiv.int/public/medias/7590/oiv-oeno-618-2020-en.pdf

About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.

Contacts

Customer Contact:
Lea Heintz
Product Manager
Bruker BioSpin AIC Division
T: +49 721 5161- 0
E: lea.heintz@bruker.com

Media Contact:
Thorsten Thiel
VP of Group Marketing
Bruker BioSpin Group
T: +49 721 5161-6500
E: thorsten.thiel@bruker.com

Bruker Corporation

NASDAQ:BRKR

Release Versions

Contacts

Customer Contact:
Lea Heintz
Product Manager
Bruker BioSpin AIC Division
T: +49 721 5161- 0
E: lea.heintz@bruker.com

Media Contact:
Thorsten Thiel
VP of Group Marketing
Bruker BioSpin Group
T: +49 721 5161-6500
E: thorsten.thiel@bruker.com

More News From Bruker Corporation

Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026

SAN DIEGO--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced new updates from Bruker Spatial Biology to be showcased at the 2026 American Association for Cancer Research (AACR) Annual Meeting. At AACR, Bruker Spatial Biology will highlight how its high-fidelity spatial platforms—designed to work together—deliver deeper insights into oncology biology and accelerate translational research. At AACR 2026, Bruker Spatial Biology will launch new cross‑platform workflows linking GeoMx...

Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management

MUNICH--(BUSINESS WIRE)--At ESCMID Global 2026, Bruker announces important portfolio enhancements across microbial identification, outbreak analysis, and reflex next‑generation sequencing (NGS) typing. These latest developments underscore Bruker’s continued commitment to advancing integrated, high‑performance solutions that support laboratories in addressing evolving infectious disease challenges. MALDI Biotyper® Workflow and Identification Enhancements To further streamline routine MALDI‑TOF w...

Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026

MUNICH--(BUSINESS WIRE)--At ESCMID Global 2026, the Bruker Microbiology & Infection Diagnostics division (Bruker Corporation, Nasdaq: BRKR) announces the European launch of MyGenius PRO®, a fully automated, sample-to-answer (S2A) molecular diagnostics system based on PCR (Polymerase Chain Reaction) technology. Designed for infectious disease diagnostics, the new S2A system enables higher throughput, continuous loading of samples, consumables, and reagents, and supports random-access operati...
Back to Newsroom